Frequently asked questions

FAQs about the license

How many installations are permitted?

FAQs about the unlock code

How to obtain and use an unlock code

FAQs about data entry

How to use the Effect direction column

Troubleshooting tips

Get support

How do I cite Comprehensive Meta Analysis Version 4?

Comprehensive Meta-Analysis Version 4
Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H.
Biostat, Englewood, NJ 2022

Join our E-mail Newsletter

Valid e-mail is required.
Learn about new meta-analysis workshops & software features, and receive special tools to help with your research.

Comprehensive Meta-Analysis

software image

Comprehensive Meta-Analysis (CMA) is a powerful computer program for meta-analysis. The program combines ease of use with a wide array of computational options and sophisticated graphics.

people working
Comprehensive Meta-Analysis

Download 10 Day Trial

"I have been using Comprehensive Meta‐Analysis for more than three years and have finished a dozen meta‐analyses with this software. The biggest advantage is that it’s easy to perform and manage the analysis. Studies can be added or removed from the analysis without modifying the data. There are a variety of effect‐size measures, including treatment difference, odds ratios, rate differences, correlations, etc. The diagnosis and transformation of the effect size is just one click away. The highquality forest plot and comprehensive meta‐regression distinguished this software from others."

Rong Zhou, PhD - Senior Biostatistician, Medpace, Cincinnati, Ohio

"I can confirm that comprehensive meta‐analysis is a very valuable tool for analyzing data. In one of my most important publications the use of forest plots constructed with Comprehensive Meta‐analysis has contributed to the success of this article. As a clinician my statistical background is not as strong as I would like it to be. However, using CMA is very straightforward and I was able to astonish my epidemiologist co‐author. I can recommend Comprehensive Meta‐Analysis to any clinical researcher."

Harm J T Rutten, MD, PhD, FRCS (London) - Head, Department Surgical Oncology, Catharina Hospital, Eindhoven, The Netherlands